Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
A comparison of the anti-Staphylococcus aureus activity of extracts from commonly used medicinal plants. ✅
Go to Publication ✅
Journal of alternative and complementary medicine (New York, N.Y.) (J Altern Complement Med ) Vol: 20 Issue 5 Pages: 375-82 Pub: 2014 May Epub: 2014 Mar 17 Authors Snowden R , Harrington H , Morrill K , Jeane L , Garrity J , Orian M , Lopez E , Rezaie S , Hassberger K , Familoni D , Moore J , Virdee K , Albornoz-Sanchez L , Walker M , Cavins J , Russell T , Guse E , Reker M , Tschudy O , Wolf J , True T , Ukaegbu O , Ahaghotu E , Jones A , Polanco S , Rochon Y , Waters R , Langland J , |
|
|
Curated database of commensal, symbiotic and pathogenic microbiota ✅
Generative Bioinformatics (Center of Excellence in Generative Medicine ) Vol: Issue Pages: Pub: 2014 Jun Epub: Authors D'Adamo Peter , |
|
|
Significant pharmacokinetic differences of berberine are attributable to variations in gut microbiota between Africans and Chinese. ✅
Go to Publication ✅
Scientific reports (Sci Rep ) Vol: 6 Issue Pages: 27671 Pub: 2016 Jun 10 Epub: 2016 Jun 10 Authors Alolga RN , Fan Y , Chen Z , Liu LW , Zhao YJ , Li J , Chen Y , Lai MD , Li P , Qi LW , |
|
|
Significant pharmacokinetic differences of berberine are attributable to variations in gut microbiota between Africans and Chinese. ✅
Go to Publication ✅
Scientific reports (Sci Rep ) Vol: 6 Issue Pages: 27671 Pub: 2016 Jun 10 Epub: 2016 Jun 10 Authors Alolga RN , Fan Y , Chen Z , Liu LW , Zhao YJ , Li J , Chen Y , Lai MD , Li P , Qi LW , |
|
|
Traditional Chinese medicines (TCMs) with varied meridians (Gui-Jing) differentially alleviate the adverse impact of Coptis chinensis on gut microbiota. ✅
Go to Publication ✅
Journal of ethnopharmacology (J Ethnopharmacol ) Vol: 307 Issue Pages: 116256 Pub: 2023 May 10 Epub: 2023 Feb 13 Authors Yang Y , Su W , Zang C , Tan Y , Zhang Y , Zhou Z , Lu W , Wu S , Zhang X , Wu C , |
|
|
Traditional Chinese medicines (TCMs) with varied meridians (Gui-Jing) differentially alleviate the adverse impact of Coptis chinensis on gut microbiota. ✅
Go to Publication ✅
Journal of ethnopharmacology (J Ethnopharmacol ) Vol: 307 Issue Pages: 116256 Pub: 2023 May 10 Epub: 2023 Feb 13 Authors Yang Y , Su W , Zang C , Tan Y , Zhang Y , Zhou Z , Lu W , Wu S , Zhang X , Wu C , |
|
|
Study on the mechanism of Coptis chinensis Franch. And its main active components in treating Alzheimer's disease based on SCFAs using Orbitrap Fusion Lumos Tribrid MS. ✅
Go to Publication ✅
Journal of ethnopharmacology (J Ethnopharmacol ) Vol: 311 Issue Pages: 116392 Pub: 2023 Jul 15 Epub: 2023 Apr 5 Authors Xie M , Gu S , Hong Y , Liu Y , Rong X , Lu W , Liu H , Algradi AM , Naseem A , Shu Z , Wang Q , |
|
|
Coptidis rhizoma inhibits growth and proteases of oral bacteria. ✅
Oral diseases (Oral Dis ) Vol: 6 Issue 5 Pages: 297-302 Pub: 2000 Sep Epub: Authors Hu JP , Takahashi N , Yamada T , |
|
|
Coptidis rhizoma inhibits growth and proteases of oral bacteria. ✅
Oral diseases (Oral Dis ) Vol: 6 Issue 5 Pages: 297-302 Pub: 2000 Sep Epub: Authors Hu JP , Takahashi N , Yamada T , |
|
|
Coptisine alleviates colitis through modulating gut microbiota and inhibiting TXNIP/NLRP3 inflammasome. ✅
Go to Publication ✅
Journal of ethnopharmacology (J Ethnopharmacol ) Vol: 335 Issue Pages: 118680 Pub: 2024 Aug 8 Epub: 2024 Aug 8 Authors Li C , Deng L , Pu M , Ye X , Lu Q , |
|
|
Coptisine alleviates colitis through modulating gut microbiota and inhibiting TXNIP/NLRP3 inflammasome. ✅
Go to Publication ✅
Journal of ethnopharmacology (J Ethnopharmacol ) Vol: 335 Issue Pages: 118680 Pub: 2024 Aug 8 Epub: 2024 Aug 8 Authors Li C , Deng L , Pu M , Ye X , Lu Q , |
|
|
Coptisine alleviates colitis through modulating gut microbiota and inhibiting TXNIP/NLRP3 inflammasome. ✅
Go to Publication ✅
Journal of ethnopharmacology (J Ethnopharmacol ) Vol: 335 Issue Pages: 118680 Pub: 2024 Aug 8 Epub: 2024 Aug 8 Authors Li C , Deng L , Pu M , Ye X , Lu Q , |
|
|
Coptisine alleviates colitis through modulating gut microbiota and inhibiting TXNIP/NLRP3 inflammasome. ✅
Go to Publication ✅
Journal of ethnopharmacology (J Ethnopharmacol ) Vol: 335 Issue Pages: 118680 Pub: 2024 Aug 8 Epub: 2024 Aug 8 Authors Li C , Deng L , Pu M , Ye X , Lu Q , |
|
|
Coptisine alleviates colitis through modulating gut microbiota and inhibiting TXNIP/NLRP3 inflammasome. ✅
Go to Publication ✅
Journal of ethnopharmacology (J Ethnopharmacol ) Vol: 335 Issue Pages: 118680 Pub: 2024 Aug 8 Epub: 2024 Aug 8 Authors Li C , Deng L , Pu M , Ye X , Lu Q , |
|
|
Coptisine alleviates colitis through modulating gut microbiota and inhibiting TXNIP/NLRP3 inflammasome. ✅
Go to Publication ✅
Journal of ethnopharmacology (J Ethnopharmacol ) Vol: 335 Issue Pages: 118680 Pub: 2024 Aug 8 Epub: 2024 Aug 8 Authors Li C , Deng L , Pu M , Ye X , Lu Q , |
|
|
Coptisine alleviates colitis through modulating gut microbiota and inhibiting TXNIP/NLRP3 inflammasome. ✅
Go to Publication ✅
Journal of ethnopharmacology (J Ethnopharmacol ) Vol: 335 Issue Pages: 118680 Pub: 2024 Aug 8 Epub: 2024 Aug 8 Authors Li C , Deng L , Pu M , Ye X , Lu Q , |
|
|
In vitro anti-Helicobacter pylori action of 30 Chinese herbal medicines used to treat ulcer diseases. ✅
Journal of ethnopharmacology (J Ethnopharmacol ) Vol: 98 Issue 3 Pages: 329-33 Pub: 2005 Apr 26 Epub: Authors Li Y , Xu C , Zhang Q , Liu JY , Tan RX , |
|
|
Large-Scale Screening of 239 Traditional Chinese Medicinal Plant Extracts for Their Antibacterial Activities against Multidrug-Resistant Staphylococcus aureus and Cytotoxic Activities. ✅
Go to Publication ✅
Pathogens (Basel, Switzerland) (Pathogens ) Vol: 9 Issue 3 Pages: Pub: 2020 Mar 4 Epub: 2020 Mar 4 Authors Kim G , Gan RY , Zhang D , Farha AK , Habimana O , Mavumengwana V , Li HB , Wang XH , Corke H , |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]
